13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP
SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 45 holding rows worth $186,779,622.
- Accession
- 0001931118-26-000003
- Filer
- CIK 1931118
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 45 entries on the cover page, a total value of $186,779,622 stated on the cover page (in dollars after the unit check, H1), rows summing to $186,779,622 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 85,098 | $18,797,297 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 443,777 | $17,928,591 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 718,354 | $16,823,851 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 366,238 | $13,008,774 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 525,592 | $8,083,605 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 180,593 | $7,429,596 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 288,677 | $7,338,169 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 37,433 | $6,836,763 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 995,353 | $6,001,979 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 425,202 | $5,693,455 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 980,768 | $5,394,224 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 418,080 | $5,075,491 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 352,896 | $5,025,239 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 2,253,550 | $4,935,275 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 9,451 | $4,605,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 54,879 | $4,371,112 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 24,703 | $3,951,492 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 47,278 | $3,689,575 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 196,853 | $3,472,487 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 83,353 | $3,026,547 | dollars as filed | |
| CORTEXYME INC | 22053A107 | COM | 858,711 | $2,876,682 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 153,313 | $2,784,164 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 96,334 | $2,780,199 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 25,469 | $2,665,840 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 88,308 | $2,398,445 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 65,273 | $2,219,935 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 255,370 | $2,088,927 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 360,000 | $1,918,800 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 148,292 | $1,856,616 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 58,677 | $1,542,618 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 38,022 | $1,452,821 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 43,230 | $1,345,318 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 513,765 | $1,212,485 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 26,249 | $1,081,721 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 12,137 | $1,057,254 | dollars as filed | |
| AARDVARK THERAPEUTICS INC | 002942100 | COM | 69,496 | $912,135 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 29,162 | $898,190 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 367,103 | $862,692 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 72,060 | $814,999 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 31,738 | $729,974 | dollars as filed | |
| PALATIN TECHNOLOGIES INC | 696077601 | COM NEW | 33,971 | $522,474 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 100,000 | $465,000 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 462,963 | $460,556 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 250,000 | $310,000 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 17,142 | $33,255 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001931118-26-000003 | this filing | 2026-02-17 | acceptance time not in the bulk data set |